Send mail to Author

Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2a and ribavirin in a large noninterventional cohort study (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    __   __   _    _      ___      ______     ___    
 / ____||  \ \\/ // | || | ||   / _ \\   /_____//   / _ \\  
/ //---`'   \ ` //  | || | ||  / //\ \\  `____ `   | / \ || 
\ \\___      | ||   | \\_/ || |  ___  || /___//    | \_/ || 
 \_____||    |_||    \____//  |_||  |_|| `__ `      \___//  
  `----`     `-`'     `---`   `-`   `-`  /_//       `---`   
                                         `-`                
 


Back to frontdoor view